Lupin Ltd. Share Price Target - 2023, 2024, 2025, 2026 and 2030

If you are looking for “ Lupin share price targets” for upcoming years, you are in the right place. Before we dive into Lupin Ltd. stock price targets, Let’s understand the Lupin company background, technical fundamentals etc.

Table of Contents

About Lupin Ltd.

Lupin Ltd. is a pharmaceutical company based in Mumbai, India. It was founded in 1968 by Desh Bandhu Gupta, a graduate of BITS Pilani and a post-graduate from Rutgers University, New Jersey. The company started as a small manufacturing unit in Mumbai and has since grown to become one of the largest pharmaceutical companies in India. Lupin has a presence in over 100 countries and is known for its focus on research and development. The company has a diverse portfolio of products, including generic drugs, branded drugs, and specialty pharmaceuticals. Lupin has received several awards and recognitions for its contributions to the pharmaceutical industry, including the prestigious FICCI Healthcare Excellence Award.

Fundamentals of Lupin Ltd.

Let’s look at the fundamentals of Lupin, based on which we can get a clear understanding of the expertise in the Pharmaceuticals & Drugs sector.

Current Market Cap: The current market cap of Lupin as of 3/11/2023, is ₹ 33,533.42
P/E Ratio: The current price-to-earning ratio of Lupin is 124.06
Sales Growth: Sales growth in last 1 year for Lupin is 8.19 %
Profit Growth: Profit growth is around -223.08 % in last 1 year

Lupin Ltd. Share Price Target Details

We have done a complete analysis of Lupin and have come up with its share price targets for upcoming years.

Lupin’s Current Share Price is ₹737

Note: These price targets of “Lupin” are only for reference purposes. This prediction is only if there are positive market sentiments, and any uncertainties in the company or global market condition are not covered in this analysis.